Saraceno G Ezequiel, Bellini Maria J, Garcia-Segura Luis M, Capani Francisco
Laboratorio de Citoarquitectura y Plasticidad Neuronal, Instituto de Investigaciones Cardiológicas "Prof. Dr. Alberto C. Taquini", Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
Interdisciplinary Institute for Neuroscience, Centre Broca Nouvelle-Aquitaine, UMR 5297, Université de Bordeaux, Bordeaux, France.
Front Pharmacol. 2018 Apr 9;9:335. doi: 10.3389/fphar.2018.00335. eCollection 2018.
Perinatal asphyxia (PA) remains as one of the most important causes of short-term mortality, psychiatric and neurological disorders in children, without an effective treatment. In previous studies we have observed that the expression of different neurodegenerative markers increases in CA1 hippocampal area of 4-months-old male rats born by cesarean section and exposed for 19 min to PA. We have also shown that a late treatment with 17β estradiol (daily dose of 250 μg/kg for 3 days) was able to revert the brain alterations observed in those animals. Based on these previous results, the main aim of the present study was to explore the mechanism by which the estrogenic treatment is involved in the reversion of the chronic neurodegenerative conditions induced by PA. We demonstrated that estradiol treatment of adult PA exposed animals induced an increase in estrogen receptor (ER) α and insulin-like growth factor receptor (IGF-1R) protein levels, an activation of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 beta/β-catenin signaling pathway and an increase in Bcl-2/Bax ratio in the hippocampus in comparison to PA exposed animals treated with vehicle. Taking together, our data suggest that the interaction between ERα and IGF-IR, with the subsequent downstream activation, underlies the beneficial effects of estradiol observed in late treatment of PA.
围产期窒息(PA)仍然是儿童短期死亡率、精神和神经疾病的最重要原因之一,且尚无有效治疗方法。在先前的研究中,我们观察到剖宫产出生并暴露于PA环境19分钟的4月龄雄性大鼠海马CA1区中,不同神经退行性标志物的表达增加。我们还表明,后期用17β雌二醇治疗(每日剂量250μg/kg,持续3天)能够逆转在这些动物中观察到的脑部改变。基于这些先前的结果,本研究的主要目的是探索雌激素治疗参与逆转PA诱导的慢性神经退行性疾病的机制。我们证明,与用载体处理的PA暴露成年动物相比,用雌二醇治疗PA暴露成年动物会导致海马中雌激素受体(ER)α和胰岛素样生长因子受体(IGF-1R)蛋白水平增加,磷脂酰肌醇3激酶/蛋白激酶B/糖原合酶激酶3β/β-连环蛋白信号通路激活,以及Bcl-2/Bax比值增加。综上所述,我们的数据表明,ERα和IGF-IR之间的相互作用以及随后的下游激活是雌二醇在PA后期治疗中观察到的有益作用的基础。